We are a biotech located in Cambridge, UK that seeks to open up new ‘druggable’ target space using a cutting-edge approach called PROTEINi® (protein interference). This technology has the ability to identify hidden, or cryptic, drug sites in disease-relevant proteins, and then target those sites with first-in-class small molecule or biologic therapeutics.